MISSO, Gabriella
MISSO, Gabriella
Dipartimento di Medicina di Precisione
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients"
2011 Correale, P; Botta, C; Basile, A; Pagliuchi, M; Licchetta, A; Martellucci, I; Bestoso, E; Apollinari, S; Addeo, R; Misso, Gabriella; Romano, O; Abbruzzese, A; Lamberti, Monica; Luzzi, L; Gotti, G; Rotundo, M; Caraglia, Michele; Tagliaferri, P.
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma
2019 Zappavigna, S.; Cossu, A. M.; Abate, M.; Misso, G.; Lombardi, A.; Caraglia, M.; Filosa, R.
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma.
2017 Ricciardiello, Filippo; Capasso, R.; Kawasaki, H.; Abate, T.; Oliva, F.; Lombardi, A.; Misso, G.; Ingrosso, D.; Leone, C. A.; Iengo, M.; Caraglia, M.
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
2024 Bocchetti, Marco; Misso, Gabriella; Zappavigna, Silvia; Scrima, Marianna; Caraglia, Michele; Pentimalli, Francesca; Cossu, Alessia Maria
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
2024 Bocchetti, Marco; Misso, Gabriella; Zappavigna, Silvia; Scrima, Marianna; Caraglia, Michele; Pentimalli, Francesca; Cossu, Alessia Maria
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors?
2013 Caraglia, M.; Misso, G.; Santini, D.
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells
2015 Grimaldi, Anna; Santini, D.; Zappavigna, S.; Lombardi, A.; Misso, Gabriella; Boccellino, Mariarosaria; Desiderio, Vincenzo; Vitiello, P. P.; DI LORENZO, Giuseppe; Zoccoli, A.; Pantano, F.; Caraglia, Michele
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
2017 Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
2017 Irace, Carlo; Misso, Gabriella; Capuozzo, Antonella; Piccolo, Marialuisa; Riccardi, Claudia; Luchini, Alessandra; Caraglia, Michele; Paduano, Luigi; Montesarchio, Daniela; Santamaria, Rita
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
2022 Ferraro, M. G.; Piccolo, M.; Misso, G.; Santamaria, R.; Irace, C.
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane
2023 Caraglia, Michele; De Stefano, Luca; Tammaro, Chiara; Scrima, Marianna; Cossu, Alessia Maria; Falco, Michela; Misso, Gabriella; Rea, Ilaria; De Luca Anna, Chiara
Bisphosphonates and cancer: what opportunities from nanotechnology?
2013 De Rosa, G; Misso, Gabriella; Salzano, G; Caraglia, Michele
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
2020 Ferraro, M. G.; Piccolo, M.; Misso, G.; Maione, F.; Montesarchio, D.; Caraglia, M.; Paduano, L.; Santamaria, R.; Irace, C.
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum
2022 Ottaiano, A.; Santorsola, M.; Perri, F.; Pace, U.; Marra, B.; Correra, M.; Sabbatino, F.; Cascella, M.; Petrillo, N.; Ianniello, M.; Casillo, M.; Misso, G.; Delrio, P.; Caraglia, M.; Nasti, G.
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports
2016 Gagliardi, Alfredo; Carbone, Claudio; Russo, Angela; Cuccurullo, Rosanna; Lucania, Anna; Cioppa, Paola Della; Misso, Gabriella; Caraglia, Michele; Tommasino, Catello; Mastrullo, Lucia
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer.
2020 Lombardi, A; Russo, M; Luce, A; Morgillo, F; Tirino, V; Misso, G; Martinelli, E; Troiani, T; Desiderio, V; Papaccio, G; Iovino, F; Argenziano, G; Moscarella, E; Sperlongano, P; Galizia, G; Addeo, R; Necas, A; Necasova, A; Ciardiello, F; Ronchi, A; Caragli, M; Grimaldi, A
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity.
2012 Ungaro, F; Conte, C; Ostacolo, L; Maglio, G; Barbieri, A; Arra, C; Misso, Gabriella; Abbruzzese, A; Caraglia, Michele; Quaglia, F.
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC)
2010 Correale, P; Remando, C; Migali, C; Marra, M; Misso, Gabriella; Arcuri, Fp; DEL VECCHIO, Mt; Carducci, A; Loiacono, L; Tagliaferri, P; Abbruzzese, A; Arancini, G; Caraglia, Michele
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients
2016 Kawasaki, H; Capasso, R; Lombardi, A; Misso, Gabriella; Abate, T; Ricciardiello, F; Ingrosso, Diego; Caraglia, Michele
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion
2020 Kawasaki, H.; Takeuchi, T.; Ricciardiello, F.; Lombardi, A.; Biganzoli, E.; Fornili, M.; De Bortoli, D.; Mesolella, M.; Cossu, A. M.; Scrima, M.; Capasso, R.; Falco, M.; Motta, G.; Motta, G.; Testa, D.; De Luca, S.; Oliva, F.; Abate, T.; Mazzone, S.; Misso, G.; Caraglia, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" | 1-gen-2011 | Correale, P; Botta, C; Basile, A; Pagliuchi, M; Licchetta, A; Martellucci, I; Bestoso, E; Apollinari, S; Addeo, R; Misso, Gabriella; Romano, O; Abbruzzese, A; Lamberti, Monica; Luzzi, L; Gotti, G; Rotundo, M; Caraglia, Michele; Tagliaferri, P. | |
| A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma | 1-gen-2019 | Zappavigna, S.; Cossu, A. M.; Abate, M.; Misso, G.; Lombardi, A.; Caraglia, M.; Filosa, R. | |
| A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. | 1-gen-2017 | Ricciardiello, Filippo; Capasso, R.; Kawasaki, H.; Abate, T.; Oliva, F.; Lombardi, A.; Misso, G.; Ingrosso, D.; Leone, C. A.; Iengo, M.; Caraglia, M. | |
| Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model | 1-gen-2024 | Bocchetti, Marco; Misso, Gabriella; Zappavigna, Silvia; Scrima, Marianna; Caraglia, Michele; Pentimalli, Francesca; Cossu, Alessia Maria | |
| Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model | 1-gen-2024 | Bocchetti, Marco; Misso, Gabriella; Zappavigna, Silvia; Scrima, Marianna; Caraglia, Michele; Pentimalli, Francesca; Cossu, Alessia Maria | |
| Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? | 1-gen-2013 | Caraglia, M.; Misso, G.; Santini, D. | |
| Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells | 1-gen-2015 | Grimaldi, Anna; Santini, D.; Zappavigna, S.; Lombardi, A.; Misso, Gabriella; Boccellino, Mariarosaria; Desiderio, Vincenzo; Vitiello, P. P.; DI LORENZO, Giuseppe; Zoccoli, A.; Pantano, F.; Caraglia, Michele | |
| Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo | |
| Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action | 1-gen-2017 | Irace, Carlo; Misso, Gabriella; Capuozzo, Antonella; Piccolo, Marialuisa; Riccardi, Claudia; Luchini, Alessandra; Caraglia, Michele; Paduano, Luigi; Montesarchio, Daniela; Santamaria, Rita | |
| Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics | 1-gen-2022 | Ferraro, M. G.; Piccolo, M.; Misso, G.; Santamaria, R.; Irace, C. | |
| Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane | 1-gen-2023 | Caraglia, Michele; De Stefano, Luca; Tammaro, Chiara; Scrima, Marianna; Cossu, Alessia Maria; Falco, Michela; Misso, Gabriella; Rea, Ilaria; De Luca Anna, Chiara | |
| Bisphosphonates and cancer: what opportunities from nanotechnology? | 1-gen-2013 | De Rosa, G; Misso, Gabriella; Salzano, G; Caraglia, Michele | |
| Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems | 1-gen-2020 | Ferraro, M. G.; Piccolo, M.; Misso, G.; Maione, F.; Montesarchio, D.; Caraglia, M.; Paduano, L.; Santamaria, R.; Irace, C. | |
| Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum | 1-gen-2022 | Ottaiano, A.; Santorsola, M.; Perri, F.; Pace, U.; Marra, B.; Correra, M.; Sabbatino, F.; Cascella, M.; Petrillo, N.; Ianniello, M.; Casillo, M.; Misso, G.; Delrio, P.; Caraglia, M.; Nasti, G. | |
| Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports | 1-gen-2016 | Gagliardi, Alfredo; Carbone, Claudio; Russo, Angela; Cuccurullo, Rosanna; Lucania, Anna; Cioppa, Paola Della; Misso, Gabriella; Caraglia, Michele; Tommasino, Catello; Mastrullo, Lucia | |
| Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. | 1-gen-2020 | Lombardi, A; Russo, M; Luce, A; Morgillo, F; Tirino, V; Misso, G; Martinelli, E; Troiani, T; Desiderio, V; Papaccio, G; Iovino, F; Argenziano, G; Moscarella, E; Sperlongano, P; Galizia, G; Addeo, R; Necas, A; Necasova, A; Ciardiello, F; Ronchi, A; Caragli, M; Grimaldi, A | |
| Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. | 1-gen-2012 | Ungaro, F; Conte, C; Ostacolo, L; Maglio, G; Barbieri, A; Arra, C; Misso, Gabriella; Abbruzzese, A; Caraglia, Michele; Quaglia, F. | |
| Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) | 1-gen-2010 | Correale, P; Remando, C; Migali, C; Marra, M; Misso, Gabriella; Arcuri, Fp; DEL VECCHIO, Mt; Carducci, A; Loiacono, L; Tagliaferri, P; Abbruzzese, A; Arancini, G; Caraglia, Michele | |
| Definition of microRNAs predictive of nodal involvement in laringeal cancer patients | 1-gen-2016 | Kawasaki, H; Capasso, R; Lombardi, A; Misso, Gabriella; Abate, T; Ricciardiello, F; Ingrosso, Diego; Caraglia, Michele | |
| Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion | 1-gen-2020 | Kawasaki, H.; Takeuchi, T.; Ricciardiello, F.; Lombardi, A.; Biganzoli, E.; Fornili, M.; De Bortoli, D.; Mesolella, M.; Cossu, A. M.; Scrima, M.; Capasso, R.; Falco, M.; Motta, G.; Motta, G.; Testa, D.; De Luca, S.; Oliva, F.; Abate, T.; Mazzone, S.; Misso, G.; Caraglia, M. |